Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jun;84(12):6241-7.
doi: 10.1128/JVI.00077-10. Epub 2010 Apr 7.

Wide variation in the multiplicity of HIV-1 infection among injection drug users

Katharine J Bar  1 , Hui Li, Annie Chamberland, Cecile Tremblay, Jean Pierre Routy, Truman Grayson, Chuanxi Sun, Shuyi Wang, Gerald H Learn, Charity J Morgan, Joseph E Schumacher, Barton F Haynes, Brandon F Keele, Beatrice H Hahn, George M Shaw
Affiliations

Wide variation in the multiplicity of HIV-1 infection among injection drug users

Katharine J Bar et al. J Virol. 2010 Jun.

Abstract

Recent studies indicate that sexual transmission of human immunodeficiency virus type 1 (HIV-1) generally results from productive infection by only one virus, a finding attributable to the mucosal barrier. Surprisingly, a recent study of injection drug users (IDUs) from St. Petersburg, Russia, also found most subjects to be acutely infected by a single virus. Here, we show by single-genome amplification and sequencing in a different IDU cohort that 60% of IDU subjects were infected by more than one virus, including one subject who was acutely infected by at least 16 viruses. Multivariant transmission was more common in IDUs than in heterosexuals (60% versus 19%; odds ratio, 6.14; 95% confidence interval [CI], 1.37 to 31.27; P = 0.008). These findings highlight the diversity in HIV-1 infection risks among different IDU cohorts and the challenges faced by vaccines in protecting against this mode of infection.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
NJ trees and Highlighter plots of HIV-1 gp160 env sequences. (A) Composite tree of 382 gp160 env sequences from all study subjects. The numerals at the nodes indicate bootstrap values for which statistical support exceeded 70%. (B) Subject ACT54869022 sequences suggest productive infection by a single virus (V1). (C) Subject HDNDRPI032 sequences suggest productive infection by as many as three viruses. (D) Subject HDNDRPI001 sequences suggest productive infection by at least five viruses with extensive interlineage recombination. Sequences are color coded to indicate viral progeny from distinct transmitted/founder viruses. Recombinant virus sequences are depicted in black. Methods for SGA, sequencing, model analysis, Highlighter plotting, and identification of transmitted/founder virus lineages are described elsewhere (18, 20, 24, 44). The horizontal scale bars represent genetic distance. nt, nucleotide.
FIG. 2.
FIG. 2.
NJ tree and Highlighter plot of HIV-1 3′ half-genome sequences from subject HDNDRPI034. Sequences emanating from 16 transmitted/founder viruses are color coded. Fourteen transmitted/founder viral lineages comprised of 2 or more identical or nearly identical sequences could be readily distinguished from recombinant sequences (depicted in black), which invariably appeared as unique sequences containing interspersed segments shared with other transmitted/founder virus lineages. The two sequences with the longest branch lengths (3F8 and G10) were interpreted to represent rare progeny of discrete transmitted/founder viruses because their unique polymorphisms far exceeded the maximum diversity estimated to occur in the first 30 days of infection (0.22%; CI, 0.15 to 0.31%) (18) and far exceeded the diversity observed within the other transmitted/founder virus lineages. The horizontal scale bar represents genetic distance.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Abrahams, M.-R., J. A. Anderson, E. E. Giorgi, C. Seoighe, K. Mlisana, L.-H. Ping, G. S. Athreya, F. K. Treurnicht, B. F. Keele, N. Wood, J. F. Salazar-Gonzalez, T. Bhattacharya, H. Chu, I. Hoffman, S. Galvin, C. Mapanje, P. Kazembe, R. Thebus, S. Fiscus, W. Hide, M. S. Cohen, S. A. Karim, B. F. Haynes, G. M. Shaw, B. H. Hahn, B. T. Korber, R. Swanstrom, and C. Williamson. 2009. Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-Poisson distribution of transmitted variants. J. Virol. 83:3556-3567. - PMC - PubMed
    1. Aceijas, C., G. V. Stimson, M. Hickman, and T. Rhodes. 2004. Global overview of injecting drug use and HIV infection among injecting drug users. AIDS 18:2295-2303. - PubMed
    1. Baggaley, R. F., M. C. Boily, R. G. White, and M. Alary. 2006. Risk of HIV-1 transmission for parenteral exposure and blood transfusion: a systematic review and meta-analysis. AIDS 20:805-812. - PubMed
    1. Brogly, S. B., J. Bruneau, J. Vincelette, F. Lamothe, and E. L. Franco. 2000. Risk behaviour change and HIV infection among injection drug users in Montreal. AIDS 14:2575-2582. - PubMed
    1. Bruneau, J., F. Lamothe, E. Franco, N. Lachance, M. Desy, J. Soto, and J. Vincelette. 1997. High rates of HIV infection among injection drug users participating in needle exchange programs in Montreal: results of a cohort study. Am. J. Epidemiol. 146:994-1002. - PubMed

Publication types

MeSH terms

Substances

Associated data